Skip to content
ClinCalc Pro
Menu
Topical ocular anaesthetic Pregnancy: VERBATIM UK SPC §4.6: 'Safety for use in pregnancy and lactation has not been established, therefore, use only when considered essential by the physician.'

Proxymetacaine 0.5% Eye Drops (Minims Proxymetacaine)

Brand names: Minims Proxymetacaine

Proxymetacaine eye drops (Minims proxymetacaine) are a single-use topical ophthalmic local anaesthetic used to provide brief corneal and conjunctival anaesthesia for diagnostic and minor procedures.

Adult dose

Dose: Topical ocular anaesthesia (adults, including the elderly). Tonometry: instil 1 or 2 drops immediately before measurement. Removal of a foreign body: instil 1 or 2 drops prior to operating. Removal of sutures: instil 1 or 2 drops 2 to 3 minutes before removal of stitches. Deep anaesthesia: instil 1 drop every 5 to 10 minutes for 5 to 7 applications.
Route: Ophthalmic — instil into the conjunctival sac of the eye to be anaesthetised. Each Minims unit should be discarded after a single use. A period of at least one minute should be allowed after administration before any other topical agent is given.
Frequency: A single instillation (1 or 2 drops) immediately before the procedure for tonometry, foreign-body removal and suture removal. For deep anaesthesia, repeated every 5 to 10 minutes for a total of 5 to 7 applications.
VERBATIM UK SPC §4.2 (Minims Proxymetacaine Hydrochloride 0.5% w/v, Eye drops solution): 'Adults (including the elderly) and children: Deep anaesthesia: Instil 1 drop every 5 - 10 minutes for 5 - 7 applications. Removal of sutures: Instil 1 or 2 drops 2 to 3 minutes before removal of stitches. Removal of foreign bodies: Instil 1 or 2 drops prior to operating. Tonometry: Instil 1 or 2 drops immediately before measurement. Do not use if the solution is more than pale yellow in colour. Each Minims unit should be discarded after a single use. A period of at least one minute should be allowed after administration of Minims Proxymetacaine hydrochloride 0.5%, before subsequent administration of other topical agents.' SCOPE: this §4.2 is COMPLETE in the bundle (no truncation marker) and covers every licensed use of the product — all four procedure regimens above are quoted, so nothing licensed has been omitted. NO MAXIMUM DOSE is stated in §4.2, so maxDose is deliberately left unpopulated; the only ceiling the label gives is the '5 - 7 applications' limit inside the deep-anaesthesia regimen, which is stated in the dose text above and must not be applied to the single-instillation regimens. DO NOT USE IF the solution is more than pale yellow in colour. THIS PRODUCT IS NOT INTENDED FOR LONG TERM USE (§4.4): regular and prolonged use of topical ocular anaesthetics, e.g. in conjunction with contact lens insertion, may cause softening and erosion of the corneal epithelium, which could produce corneal opacification with accompanying loss of vision. MISCIBILITY: Minims Proxymetacaine hydrochloride is not miscible with fluorescein; fluorescein can be added to the eye after it has been anaesthetised with proxymetacaine. Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during and following instillation — the SPC notes this is especially advisable in children. Use with caution in an inflamed eye, as hyperaemia greatly increases the rate of systemic absorption through the conjunctiva. Tonometers soaked in sterilising or detergent solutions should be thoroughly rinsed with sterile distilled water prior to use. §4.5 Interactions: 'None stated.'

Paediatric dose

Dose: Children: as for adults — the SPC addresses 'Adults (including the elderly) and children' together and gives no separate paediatric figure. Tonometry 1 or 2 drops immediately before measurement; foreign-body removal 1 or 2 drops prior to operating; suture removal 1 or 2 drops 2 to 3 minutes before removal; deep anaesthesia 1 drop every 5 to 10 minutes for 5 to 7 applications.
Route: Ophthalmic — instil into the conjunctival sac; single-use Minims unit discarded after use
Frequency: As for adults — single instillation immediately before the procedure, or every 5 to 10 minutes for 5 to 7 applications for deep anaesthesia
THIS IS THE LABEL'S OWN PAEDIATRIC WORDING, not a scaled adult figure — §4.2 gives one regimen for 'Adults (including the elderly) and children'. CONTRAINDICATED IN PREMATURE BABIES, verbatim §4.3: 'In view of the immaturity of the enzyme system which metabolises the ester type local anaesthetics in premature babies, this product should be avoided in these patients.' No dosePerKg or concentration is populated because this is a drop-count topical preparation and the label contains no per-kilogram figure — none has been invented. §4.4 specifically advises compressing the lacrimal sac at the medial canthus for a minute during and after instillation to reduce systemic absorption, noting 'It is especially advisable in children'. Protection of the eye from rubbing, irritating chemicals and foreign bodies during the period of anaesthesia is very important; children should be kept from touching the eye until the anaesthesia has worn off. Verify any paediatric use against a children's formulary.

Dose independently re-sourced from UK Summary of Product Characteristics (SPC) via the eMC — clinician-reviewed. Always confirm against the product SmPC and your local formulary before prescribing.

Contraindications

  • Known hypersensitivity to any component of the preparation — 'Do not use in patients with a known hypersensitivity to any component of the preparation'
  • Premature babies — 'In view of the immaturity of the enzyme system which metabolises the ester type local anaesthetics in premature babies, this product should be avoided in these patients'
  • Not a contraindication but an explicit caution (§4.4): use cautiously and sparingly in patients with known allergies, cardiac disease or hyperthyroidism, because of the increased risk of sensitivity reactions
  • Do not use if the solution is more than pale yellow in colour

Side effects

  • Pupillary dilatation or cycloplegic effects — rarely observed with proxymetacaine hydrochloride preparations
  • Irritation of the conjunctiva, or other toxic reactions — have occurred only rarely
  • A severe, immediate-type apparently hyperallergic corneal reaction may rarely occur: acute, intense and diffuse epithelial keratitis; a grey ground-glass appearance; sloughing of large areas of necrotic epithelium; corneal filaments; and sometimes iritis with descemetitis
  • With regular and prolonged use (not intended for long term use): softening and erosion of the corneal epithelium, which could produce corneal opacification with accompanying loss of vision

Monitoring

  • Protect the eye from rubbing, irritating chemicals and foreign bodies throughout the period of anaesthesia — advise the patient to avoid touching the eye until the anaesthesia has worn off
  • Watch for signs of local irritation or hypersensitivity; discontinue if a severe corneal reaction develops
  • Where repeated or prolonged instillation has occurred, examine the cornea for epithelial softening, erosion or opacification
  • Compress the lacrimal sac at the medial canthus for a minute during and after instillation to limit systemic absorption, especially in children and in an inflamed (hyperaemic) eye

Clinical monograph

How it works

Proxymetacaine is an ester local anaesthetic that reversibly blocks sodium channels in ocular surface sensory nerves, abolishing pain transmission for a short period.

Prescribing in practice

  • Topical ocular anaesthetics must never be supplied for repeated or take-home use, as repeated application causes corneal toxicity and can result in severe, sight-threatening keratopathy.
  • Single-use Minims units should be discarded after one application to maintain sterility.
  • The blink reflex is temporarily lost, so the eye must be protected until sensation returns.

Monitoring

Monitoring is clinical; confirm return of corneal sensation and surface integrity after the procedure.

Counselling the patient

  • The eye will feel numb briefly; avoid rubbing or touching it until feeling returns.
  • Protect the eye from injury while it is numb.
  • These drops are for use by clinicians during procedures only, not for treating pain at home.

Evidence & guidelines

Single-use anaesthetic Minims are widely used for ophthalmic assessment, with SPC and MHRA advice cautioning against unsupervised repeated use.

Reference: RCOphth Ophthalmic Trauma Guidelines; Minims Proxymetacaine SPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.